MALVERN, PA--(Marketwire - October 29, 2008) - Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced financial results and operational highlights for the quarter ended September 30, 2008. For the third quarter of 2008, Auxilium reported net revenues of $32.6 million compared to net revenues of $26.2 million in the third quarter of 2007.
